Primary Central Nervous Lymphoma
1 clinical trials · Condition
◉ Watch Primary Central Nervous Lymphoma
| Record | Firm | Date |
|---|---|---|
| Study of Ibrutinib in Patients With Relapsed or Refractory Primary Central Nervous Lymphoma or Intraocular Lymphoma (NCT02542514) | The Lymphoma Academic Research Organisation | 2015-09-01 |
Track Primary Central Nervous Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.